Trading Snapshot – Irrc (7325.T)
Irrc closed the session at JPY 721, reflecting a 1.13 % uptick within the 24‑hour window ending 06:29 PM Central Europe on Thursday, 22 October 2026. The stock’s liquidity remains modest, with only 8.1 million shares outstanding and a 24‑hour volume of roughly JPY 718 k, underscoring its status as a niche play in the Japanese life‑insurance sector.
The company’s market capitalization sits at JPY 5.8 bn, a figure that has been steadily climbing, marking a 3.31 % increase since the close of the previous month. A key technical indicator—the 200‑day simple moving average—currently sits at JPY 774.16, suggesting that the recent rally has nudged the price closer to the long‑term equilibrium. Over the past year, Irrc’s highest bid reached JPY 991 on 24 February 2026, while the 52‑week low of JPY 651 was recorded on 29 June 2026, indicating a healthy trading range.
Contextual Performance
Comparing Irrc’s short‑term trajectory with peers provides additional perspective:
- Epco (2311.T) rose 1.29 % to JPY 788, trading above its 17.66 P/E, with a market cap of JPY 7 bn.
- Tokyo Automatic Machinery (6360.T) remained flat at JPY 4,800, a staggering 708.58 P/E on a JPY 6.9 bn valuation.
- Chiome Bioscience (4583.T) surged 6.82 % to JPY 92, matching the same JPY 6.9 bn market cap.
- Asahipen (4623.T) held steady at JPY 1,876, with an 8.78 P/E on a JPY 6.9 bn base.
- Kimura (7461.T) edged up 0.64 % to JPY 470, a 9.48 P/E on a JPY 6.9 bn valuation.
While peer prices vary widely, Irrc’s modest appreciation aligns with its conservative growth profile and stable dividend strategy.
Forward Outlook
Irrc’s core operations—life‑insurance agency and sales‑support services—position it to benefit from Japan’s aging demographics and the growing demand for tailored financial products. The company’s direct‑shop model ensures high customer engagement, while its online presence via www.irrc.co.jp offers scalability without compromising service quality.
Given the current market cap and the stock’s proximity to its 200‑day SMA, a cautious bullish stance is warranted. If the company can sustain its service‑delivery momentum and leverage digital channels, Irrc may continue to outperform its peers, particularly as the sector seeks to capture a larger share of the aging population’s insurance needs.
This analysis is based on publicly available trading data and does not constitute investment advice.





